Eir Ventures: Funding, Team & Investors | Startup Intros

Loading organizations...

Eir Ventures: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jun 1, 2024	Moleculent	$26.0M Series A	ARCH Venture Partners, Eir Ventures	—
Dec 11, 2023	Hoba Therapeutics	$24.8M Series A	Gonçalo Rebelo, Kenji Harada	EIFO, Camilla Petrycer Hansen
Oct 27, 2022	Henlez	$1.0M Seed	Eir Ventures, Viktor Drvota	—
Sep 1, 2022	Pretzel Therapeutics	$73.0M Series A	ARCH Venture Partners, Alaa Halawa	Amadeus Capital Partners, Cambridge Innovation Capital, Foresite Capital, Future Planet Capital, Krishna Yeshwant, HealthCap, Mubadala, Parkwalk Advisors, QVentures, Sanofi Ventures, Section 32, Paolo Di Giorgio, Cambridge Enterprise, Google Ventures, GU Ventures, Invus, Karolinska Institutet Holding
Jun 9, 2022	Synklino	$31.9M Series A	—	PKA, Vaekstfonden
Mar 11, 2022	Scenic Biotech	$31.0M Series A	Michael Wacker, Stephan Christgau, Stephane Verdood	BioGeneration Ventures, INKEF Capital, Oxford Science Enterprises
Jan 1, 2021	IO Biotech	$150.0M Series B	Priyanka Belawat	Earlybird Venture Capital, EQT Life Sciences, Kurma Partners, Vivo Capital, Avoro Capital Advisors, Idinvest Partners, Christian E. Elling, Novo Seeds, PFM Health Sciences, RA Capital Management, Samsara BioCapital, Serrado Capital, Sunstone Life Science Ventures
Sep 29, 2020	Galecto	$64.0M Other Equity	Stephan Christgau, Guy Levy	Asymmetry Capital Management, Bristol Myers Squibb, Canica, Cormorant Asset Management, Hans Schambye, Hadean Ventures, HBM Healthcare Investments, Janus Henderson Investors, Maverick Ventures, Novo Holdings, OrbiMed, Seventure Partners, Sphera, Sunstone Capital, Ysios Capital